These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33422606)

  • 1. Synthesis of novel quinoxaline-alkynyl derivatives and their anti-Mycobacterium tuberculosis activity.
    Raphoko LA; Lekgau K; Lebepe CM; Leboho TC; Matsebatlela TM; Nxumalo W
    Bioorg Med Chem Lett; 2021 Mar; 35():127784. PubMed ID: 33422606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, in vitro antitubercular activity and 3D-QSAR of novel quinoxaline derivatives.
    Puratchikody A; Natarajan R; Jayapal M; Doble M
    Chem Biol Drug Des; 2011 Dec; 78(6):988-98. PubMed ID: 21951363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives.
    Moreno E; Ancizu S; Pérez-Silanes S; Torres E; Aldana I; Monge A
    Eur J Med Chem; 2010 Oct; 45(10):4418-26. PubMed ID: 20656380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis agents.
    Jaso A; Zarranz B; Aldana I; Monge A
    J Med Chem; 2005 Mar; 48(6):2019-25. PubMed ID: 15771444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, 3D-QSAR analysis and biological evaluation of quinoxaline 1,4-di-N-oxide derivatives as antituberculosis agents.
    Pan Y; Li P; Xie S; Tao Y; Chen D; Dai M; Hao H; Huang L; Wang Y; Wang L; Liu Z; Yuan Z
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4146-53. PubMed ID: 27426298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tubercular activity of novel class of spiropyrrolidine tethered indenoquinoxaline heterocyclic hybrids.
    Arumugam N; Almansour AI; Suresh Kumar R; Ibrahim Alaqeel S; Siva Krishna V; Sriram D
    Bioorg Chem; 2020 Jun; 99():103799. PubMed ID: 32247109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antitubercular and antimicrobial activities of 1-substituted quinoxaline-2,3(1H,4H)-diones.
    Ramalingam P; Ganapaty S; Rao ChB
    Bioorg Med Chem Lett; 2010 Jan; 20(1):406-8. PubMed ID: 19962890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synthesis and antituberculosis activity of 5-alkynyl uracil derivatives.
    Platonova YB; Volov AN; Tomilova LG
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127351. PubMed ID: 32631549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of novel 5-alkynyl pyrimidine nucleosides derivatives: Influence of C-6-substituent on antituberculosis activity.
    Volov AN; Volov NA; Platonova YB
    Bioorg Med Chem Lett; 2021 Sep; 48():128261. PubMed ID: 34265421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel anti-tuberculosis agents with pyrrolo[1,2-a]quinoxaline-based scaffold.
    Wang T; Tang Y; Yang Y; An Q; Sang Z; Yang T; Liu P; Zhang T; Deng Y; Luo Y
    Bioorg Med Chem Lett; 2018 Jun; 28(11):2084-2090. PubMed ID: 29748048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective activity against Mycobacteriumtuberculosis of new quinoxaline 1,4-di-N-oxides.
    Vicente E; Pérez-Silanes S; Lima LM; Ancizu S; Burguete A; Solano B; Villar R; Aldana I; Monge A
    Bioorg Med Chem; 2009 Jan; 17(1):385-9. PubMed ID: 19058970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-
    Palos I; Luna-Herrera J; Lara-Ramírez EE; Loera-Piedra A; Fernández-Ramírez E; Aguilera-Arreola MG; Paz-González AD; Monge A; Wan B; Franzblau S; Rivera G
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29914062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of new 2-acetyl and 2-benzoyl quinoxaline 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents.
    Jaso A; Zarranz B; Aldana I; Monge A
    Eur J Med Chem; 2003 Sep; 38(9):791-800. PubMed ID: 14561478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Antibacterial Activity of Mefloquine-Based Analogs Against Sensitive and Resistant Mycobacterium tuberculosis Strains.
    da Silva Araújo A; Moraes AM; Lourenço MCS; Pessoa CO; da Silva ET; de Souza MVN
    Curr Top Med Chem; 2019; 19(9):683-689. PubMed ID: 30836914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and antimycobacterial activity of various 3-(4-(substitutedsulfonyl)piperazin-1-yl)benzo[d]isoxazole derivatives.
    Naidu KM; Suresh A; Subbalakshmi J; Sriram D; Yogeeswari P; Raghavaiah P; Chandra Sekhar KV
    Eur J Med Chem; 2014 Nov; 87():71-8. PubMed ID: 25240097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinoxaline Moiety: A Potential Scaffold against
    Montana M; Montero V; Khoumeri O; Vanelle P
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443334
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis of alkynylated 1,2,4-oxadiazole/1,2,3-1H-triazole glycoconjugates: Discovering new compounds for use in chemotherapy against lung carcinoma and Mycobacterium tuberculosis.
    Melo de Oliveira VN; Flávia do Amaral Moura C; Peixoto ADS; Gonçalves Ferreira VP; Araújo HM; Lapa Montenegro Pimentel LM; Pessoa CDÓ; Nicolete R; Versiani Dos Anjos J; Sharma PP; Rathi B; Pena LJ; Rollin P; Tatibouët A; Nascimento de Oliveira R
    Eur J Med Chem; 2021 Aug; 220():113472. PubMed ID: 33940463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents.
    Srinivasarao S; Nandikolla A; Suresh A; Ewa AK; Głogowska A; Ghosh B; Kumar BK; Murugesan S; Pulya S; Aggarwal H; Sekhar KVGC
    Bioorg Chem; 2020 Jul; 100():103955. PubMed ID: 32464405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graph Theoretical Analysis, In Silico Modeling, Synthesis, Anti-Microbial and Anti-TB Evaluation of Novel Quinoxaline Derivatives.
    Saravanan G; Selvam TP; Alagarsamy V; Kunjiappan S; Joshi SD; Indhumathy M; Kumar PD
    Drug Res (Stuttg); 2018 May; 68(5):250-262. PubMed ID: 29065435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Chloro-2-thiophenyl-1,2,3-triazolylmethyldihydroquinolines as dual inhibitors of Mycobacterium tuberculosis and influenza virus: Synthesis and evaluation.
    Marvadi SK; Krishna VS; Sinegubova EO; Volobueva AS; Esaulkova YL; Muryleva AA; Tentler DG; Sriram D; Zarubaev VV; Kantevari S
    Bioorg Med Chem Lett; 2019 Sep; 29(18):2664-2669. PubMed ID: 31375291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.